Integrin α4 Enhances Metastasis and May Be Associated with Poor Prognosis in MYCN-low Neuroblastoma.
High-risk neuroblastoma is associated with an overall survival rate of 30-50%. Neuroblastoma-expressed cell adhesion receptors of the integrin family impact cell adhesion, migration, proliferation and survival. Integrin α4 is essential for neural crest cell motility during development, is highly exp...
Main Authors: | Shanique A Young, Katelyn E McCabe, Alena Bartakova, Joe Delaney, Donald P Pizzo, Robert O Newbury, Judith A Varner, David D Schlaepfer, Dwayne G Stupack |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4431816?pdf=render |
Similar Items
-
MYCN Function in Neuroblastoma Development
by: Jörg Otte, et al.
Published: (2021-01-01) -
Analysis of the MYCN amplicon in neuroblastoma
by: Kenyon, Rebecca Margaret
Published: (1996) -
Implementation of the plasma MYCN/NAGK ratio to detect MYCN amplification in patients with neuroblastoma
by: Yan Su, et al.
Published: (2020-11-01) -
Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplification
by: Zhi-Xia Yue, et al.
Published: (2019-11-01) -
MYCN amplification and ATRX mutations are incompatible in neuroblastoma
by: Maged Zeineldin, et al.
Published: (2020-02-01)